0020

Wanbangde Pharmaceutical Holding Group Co., Ltd. (002082)

Market Closed
20 Dec, 06:57
XSHE XSHE
¥
7. 05
-0.36
-4.86%
¥
3.91B Market Cap
- P/E Ratio
0.32% Div Yield
11,821,800 Volume
- Eps
¥ 7.41
Previous Close
Day Range
6.95 7.15
Year Range
3.7 7.78
Want to track 002082 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

002082 Chart

Wanbangde Pharmaceutical Holding Group Co., Ltd. Profile

Drug Manufacturers - Specialty & Generic Industry
Healthcare Sector
- CEO
XSHE Exchange
CNE000001P94 ISIN
China Country
1,605 Employees
- Last Dividend
10 Jun 2008 Last Split
- IPO Date

Overview

Wanbangde Pharmaceutical Holding Group Co., Ltd., originally established in 1985 and headquartered in Taizhou City, China, has significantly evolved over the years. Initially known as Wanbangde New Building Materials Co., Ltd., the company underwent a notable transformation in April 2020 when it redirected its focus towards the pharmaceutical industry, consequently changing its name to better reflect its new orientation. Today, it is recognized for its comprehensive involvement in the research and development, production, and sale of various pharmaceutical products and medical equipment not just within China but on an international scale. The company’s operations are segmented into two main areas: Pharmaceutical Production and Sales, and Medical Equipment and Personal Equipment Production and Sale, catering to a broad spectrum of healthcare needs from medication to sophisticated medical devices.

Products and Services

Wanbangde Pharmaceutical Holding Group Co., Ltd. offers a wide range of products and services aimed at enhancing healthcare outcomes. These include:

  • Pharmaceutical Products: The company prides itself on a diverse drug portfolio designed to treat a variety of ailments. Some of its key focus areas include cardiovascular and cerebrovascular diseases, as well as conditions affecting the nervous, respiratory, mental, and digestive systems. This extensive range demonstrates the company's commitment to addressing multifaceted health challenges.
  • Medical Devices: In addition to pharmaceuticals, the company has developed a noteworthy line of medical devices. This includes orthopedic implant devices such as thoracolumbar fusion, cervical fusion, and spinal internal fixation systems. Independent fusion devices and unicompartmental knee joints are also part of its innovative product offering. These devices play a crucial role in supporting patient recovery and improving quality of life.
  • Medical Equipment and Consumables: Beyond implants, Wanbangde Pharmaceutical is dedicated to supplying essential medical equipment and disposable sterile medical polymer consumables. These cover a wide array of healthcare needs, ensuring that medical professionals are well-equipped to provide care.
  • Protective Equipment: Recognizing the importance of safety in healthcare settings, the company also manufactures protective equipment designed to safeguard both medical personnel and patients alike. This line of products is crucial, especially in contexts requiring stringent infection control measures.
  • Hospital Engineering Services: Extending beyond tangible products, Wanbangde Pharmaceutical offers hospital engineering services, contributing to the design and construction of healthcare facilities. This comprehensive approach facilitates the creation of functional and efficient medical spaces, optimizing the delivery of care.

Contact Information

Address: No. 28, Baizhang North Road
Phone: 86 57 6861 83999